---
brand_name: "NEO-MEDROL ACETATE"
generic_name: "METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE"
slug: "methylprednisolone-acetate-neomycin-sulfate-5-eq-3-5mg-base-gm"
canonical_url: "https://medichelpline.com/drug-index/methylprednisolone-acetate-neomycin-sulfate-5-eq-3-5mg-base-gm"
content_type: "drug_monograph"
route: "TOPICAL"
drug_class: "General Medications"
fda_updated_at: "1993-01-22T00:00:00.000Z"
license: "Drugs@FDA Public Domain / Informational Use"
---
# NEO-MEDROL ACETATE (METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE)
## Clinical Monograph Metadata
- **Canonical URL:** https://medichelpline.com/drug-index/methylprednisolone-acetate-neomycin-sulfate-5-eq-3-5mg-base-gm
- **Generic / Active Ingredient:** METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
- **Brand Name:** NEO-MEDROL ACETATE
- **Administration Route:** TOPICAL
- **Pharmacological Class:** General Medications
- **FDA Data Timestamp:** 1993-01-22T00:00:00.000Z
## Primary Indication & Clinical Use
Marketing status: Discontinued
## Monograph Summary

Approval overview NEO-MEDROL ACETATE is listed in Drugs@FDA under application 060611 (ANDA). Marketing status: Discontinued Active ingredient METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE Form and strength CREAM;TOPICAL - 0.25%;EQ 3.5MG BASE/GM Sponsor PHARMACIA AND UPJOHN Submission history Latest submission status date: 1993-01-22 00:00:00. Submission type: SUPPL.

## Primary Sources & FDA Regulatory Records
- [Drugs@FDA Primary Database](https://www.accessdata.fda.gov/scripts/cder/daf/) (Reference Slug: `methylprednisolone-acetate-neomycin-sulfate-5-eq-3-5mg-base-gm`)
## Navigation
- [← Back to Drug Index Hub](https://medichelpline.com/drug-index.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.